Mostly Markets
Subscribe
Stocks/Financials/Life & Health Insurance

MetLifeMET

Life & Health Insurance · New York City, New York · In the S&P 500
Cheaper than peers
$100.02−0.80%After hours: $100.02 (0.00%)At the close, 30 Oct · Prices from CNBC, may be delayed
▲ 27.7% over 1 year
MetLife over 1 yearDaily close, $, to 30 Oct 2026
$70$80$90Nov2026MarMayJulSep$100.02$80NovMarJul$100.02
Source: Nasdaq daily closes
Market value$63.56B
Price to earnings19.1x
Forward P/E9.3x
Dividend yield2.37%
Year to date+26.7%
One year+27.7%
Next earningsWed 4 Nov, after the close
SectorFinancials
52-week range (closes)
$67.70$103.57

Quality and valuation

How MetLife compares with other financials stocks. A description, not a recommendation.

MetLife and 4 life & health insurance peers. Across: valuation (P/E) against the sector. Up: business quality against the sector. Hover or tap a logo for its numbers.

Business quality: weaker than mostValuation: cheaper than most

A weaker business than most financials companies, priced below most of them.

MetLife trades at 9.3 times the next 12 months of expected earnings, against a median of 13.0x for the 84 financials stocks we cover. The quality score blends where it ranks on revenue growth, gross margin, operating margin and free-cash-flow margin (net margin for banks and insurers) over the last 12 months, from SEC filings.

  • Revenue grew slower than the sector median: +8.7% vs +10.2%
  • Less profitable (operating margin): 8.3% vs 22.3%
MET trades at 9.3x forward earnings, below the sector medianForward p/e, Life & Health Insurance peers
PRU8.8xMET9.3xGL9.8xPFG11.6xAFL16.8xSector median 13.0xPRU8.8xMET9.3xGL9.8xPFG11.6xAFL16.8xSector median 13.0x
Source: CNBC quotes; Mostly Markets
At 19.1x earnings, MET is pricier than its average since Aug 2024Price over the last 12 months of reported (GAAP) diluted EPS
P/EUsual range (±1 s.d.)
15xAverage 16.0x2025202619.1x15xAverage 16.0x2025202619.1x
Source: Nasdaq prices; SEC filings

Financials

From MetLife's SEC filings, through the quarter ending 30 Jun 2026. Hover or tap a bar for its value.

Revenue grew 10.5% from a year earlierQuarterly revenue, $bn, latest Q2 ’26
$0bn$10bn$20bnQ3 ’24Q1 ’25Q3 ’25$19.1bnQ2 ’26$0bn$10bn$20bnQ3 ’24Q1 ’25Q3 ’25$19.1bnQ2 ’26
Source: SEC filings
Growth sped up to +10.5% last quarterRevenue growth, year on year, %
0%10%20%Q3 ’24Q1 ’25Q3 ’2510.5%Q2 ’260%20%Q3 ’24Q1 ’25Q3 ’2510.5%Q2 ’26
Source: SEC filings
Operating margin was 8.4% last quarterOperating income as a share of revenue, %
0%2%5%8%Q3 ’24Q1 ’25Q3 ’258.4%Q2 ’260%5%Q3 ’24Q1 ’25Q3 ’258.4%Q2 ’26
Source: SEC filings
Diluted EPS was $1.09 last quarterQuarterly diluted earnings per share, $
$0.0$0.5$1.0$1.5Q3 ’24Q1 ’25Q3 ’25$1.09Q2 ’26$0$1Q3 ’24Q1 ’25Q3 ’25$1.09Q2 ’26
Source: SEC filings
Last 12 monthsMETSector median
Revenue growth+8.7%+10.2%
Operating margin8.3%22.3%
Price to earnings19.1x14.6x

Stories on MetLife

We haven't written about MetLife yet. Follow it, and its first story will show under My stocks on the front page.

Similar companies

Life & Health Insurance, by market value.

CompanyPriceTodayYTDValue
AFLAflac$123.89+0.28%+12.4%$62.11B
PRUPrudential Financial$116.45−0.36%+3.2%$40.17B
PFGPrincipal Financial Group$111.63−1.78%+26.6%$23.75B
GLGlobe Life$159.08−0.85%+13.7%$12.22B